Your session is about to expire
← Back to Search
Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com
Phase 2 & 3
Waitlist Available
Led By Amit N. Patel, MD, MS
Research Sponsored by Amit N. Patel MD MS
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Summary
This is the clinical registry of cell based therapies that is available to researchers around the world. The registry is web based. All researches must provide IRB approval to the coordinating site- University of Utah in order to obtain access to the registry. The are predetermined case report forms for cardiovascular diseases that are currently in clinical trials- including demographics, safety, and possible efficacy end-points. All investigators have access to their own data. The servers are U.S. HIPPA compliant and protected with secure back-up.
Eligible Conditions
- Cardiovascular Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: cell therapyExperimental Treatment1 Intervention
Patient receiving active biologic
Group II: controlPlacebo Group1 Intervention
Patient receiving placebo or standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cell therapy
2012
Completed Phase 3
~3800
Find a Location
Who is running the clinical trial?
Amit N. Patel MD MSLead Sponsor
Amit N. Patel, MD, MSPrincipal InvestigatorUniversity of Utah